Application no. and date | 10010044.5 (espacenet) (Federated) (European Patent Register), 20041116 | Patent/reg. no. and date | DK/EP 2295073, 20140423 | Publication date | 20110316 | Priority no. and date | US 520842 P, 20031117, US 532426 P, 20031224 | EP pub. no. and date |
EP 2295073 20110316 | Effective date | | Applicant/owner | Genentech, Inc., 1 DNA Way
South San Francisco CA 94080-4990, US | Applicant ref. no. | P81403584DK00E | Inventor | SMITH, Victoria, 19 Dwight Road
Burlingame, CA 94010, US, POLSON, Andrew, 281 Berkeley Way
San Francisco, CA 94131, US, EATON, Dan, 45 Inverness Drive
San Rafael, CA 94901, US, Desauvage, Frederic, 187 Shooting Star Isle
Forster City, CA 94404, US, Ebens, Allen, 1932 Arroyo Avenue
San Carlos, CA 94070, US, Crowley, Craig, 151 Durazno Way
Portola Valley, CA 94028, US | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | Opponent | | IPC Class | C07K 16/30 (2006.01) | Title | ANTISTOF MOD CD22 TIL BEHANDLING AF TUMOR AF HÆMATOPOIETISK OPRINDELSE | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | Udløbet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|